- Home
- CORT vs ACHC Comparison
CORT vs ACHC Comparison
Compare CORT & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CORT | ACHC |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CORT | ACHC |
|---|---|---|
| Price | $88.23 | $14.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $139.00 | $24.38 |
| AVG Volume (30 Days) | 663.7K | ★ 3.4M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.87 | ★ 1.18 |
| Revenue | $741,172,000.00 | ★ $3,265,548,000.00 |
| Revenue This Year | $23.79 | $6.50 |
| Revenue Next Year | $40.97 | $4.38 |
| P/E Ratio | $99.75 | ★ $12.13 |
| Revenue Growth | ★ 17.92 | 4.58 |
| 52 Week Low | $49.00 | $12.63 |
| 52 Week High | $117.33 | $47.08 |
Technical Indicators
Market Signals| Indicator | CORT | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 34.23 |
| Support Level | $81.31 | $13.60 |
| Resistance Level | $87.19 | $15.55 |
| Average True Range (ATR) | 2.86 | 0.95 |
| MACD | 0.74 | 0.08 |
| Stochastic Oscillator | 93.81 | 31.52 |
Price Performance
Historical ComparisonAbout CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.